MCRB - Seres Therapeutics, Inc. (MCRB) Q1 2025 Earnings Call Transcript
2025-05-07 14:18:22 ET
Seres Therapeutics, Inc. (MCRB)
Q1 2025 Earnings Call
May 7, 2025 08:30 ET
Company Participants
Carlo Tanzi - Investor Relations
Eric Shaff - President and Chief Executive Officer
Marella Thorell - Chief Financial Officer
Matthew Henn - Chief Scientific Officer
Terri Young - Chief Commercial and Strategy Officer
Dennis Walling - Senior Vice President, Clinical Development
Conference Call Participants
Caroline Pötsch-Hennig - JPMorgan
Joseph Thome - TD Cowen
John Newman - Canaccord
Presentation
Operator
Ladies and gentlemen, thank you for standing by. My name is Desiree, and I will be your conference operator today. At this time, I would like to welcome everyone to the Seres Therapeutics First Quarter 2025 Earnings Conference Call. [Operator Instructions] I would now like to turn the conference over to Dr. Carlo Tanzi of Investor Relations. You may begin.
Carlo Tanzi
Thank you and good morning. Our press release with the company’s first quarter 2025 financial results and business updates became available at 7 a.m. Eastern Time this morning and can be found on the Investors and News section of the company’s website. The company has also posted an updated corporate presentation to the website....
Seres Therapeutics, Inc. (MCRB) Q1 2025 Earnings Call Transcript